Biosortia Microbiomics
PrivateLast Round
Series A
Nov 1, 2012
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biosortia Microbiomics operates in Healthcare & Life Sciences and is based in Dublin, Ohio. Its latest recorded funding round was a Series A round in November 2012.
Biosortia Microbiomics is a drug discovery company that utilizes its proprietary Industrial-Scale Microbiome Mining (ISMM) platform to harvest and analyze microbial communities for novel small molecules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosortia Microbiomics Comparables
Compare Biosortia Microbiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sirenas Marine Discovery | 87% | |
| Ginkgo Bioworks | 80% | |
| MyxoTech GmbH | 73% |
For institutional investors. Book with your work email.
Biosortia Microbiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 1, 2012 | ||||
| Grant | Oct 26, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biosortia Microbiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Air Force Research Laboratory | Grant |
| Defense Advanced Research Projects Agency | Grant |
| US Department of Energy (ARPA-E) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 33% MoM, reaching 1.9K.
- Nov 8, 2025
Monthly visitors increased 44% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Biosortia Microbiomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biosortia Microbiomics's valuation, stock price, and market status.
Is Biosortia Microbiomics a public or private company?
Biosortia Microbiomics is a private company.
What is the current stock price of Biosortia Microbiomics?
Biosortia Microbiomics is a private company, so its shares have no public market price. Caplight tracks Biosortia Microbiomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biosortia Microbiomics worth (valuation)?
Valuation information for Biosortia Microbiomics is not publicly available.
Can I buy Biosortia Microbiomics stock?
Biosortia Microbiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biosortia Microbiomics's last funding round?
Biosortia Microbiomics's most recent funding round was Series A on November 1, 2012.
Who are the main investors in Biosortia Microbiomics?
Key investors in Biosortia Microbiomics include U.S. Air Force Research Laboratory, Defense Advanced Research Projects Agency, US Department of Energy (ARPA-E).
Will Biosortia Microbiomics IPO soon?
No public IPO plans have been announced for Biosortia Microbiomics.
How can I track Biosortia Microbiomics secondary market activity?
Caplight tracks bids, offers, and trades in Biosortia Microbiomics's shares on secondary markets.